Improvement in cardiac function in our patient followed the administration of Tocilizumab, which is an IL‐6 inhibitor, improves cytokine release syndrome, and has also been reported to be effective in ARDS in a prior study.21 This evidence concerns the gene IL6 and acute respiratory distress syndrome.